Alzheimer’s Reversal

Biogen revised its experimental Alzheimer’s drug offering new hope for millions sending its stock to record gains. Meg Tirrell reports.

This entry was posted in Biotech & Pharmaceuticals, Health Care, NBR Show Clips. Bookmark the permalink.

Leave a Reply